FDA Inspection 1322218 — Alora Pharmaceuticals LLC

Alora Pharmaceuticals LLC — FEI 3036012598

The FDA completed an inspection of Alora Pharmaceuticals LLC on Apr 13, 2026 in Alpharetta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Apr 13, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Alpharetta, GA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.